Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 6,834 |
| Other current assets | 0 | 0 | 0 | 53 |
| TOTAL | $N/A | $N/A | $N/A | $6,887 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 1,005 |
| TOTAL | $N/A | $N/A | $N/A | $1,005 |
| Total Assets | $N/A | $N/A | $N/A | $7,989 |
| Liabilities | ||||
| Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $2,852 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | N/A | 2,991 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 67 |
| TOTAL | $N/A | $N/A | $N/A | $3,058 |
| Total Liabilities | $N/A | $N/A | $N/A | $6,046 |
| Shareholders' Equity | ||||
| Retained earnings | N/A | N/A | N/A | -17,132 |
| Other shareholders' equity | 0 | 0 | 0 | 19,075 |
| TOTAL | $N/A | $N/A | $N/A | $1,943 |
| Total Liabilities And Equity | $0 | $0 | $0 | $7,989 |